New app aims to boost mental strength in hospitalized teens with cancer

NCT ID NCT07228533

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will test a new mobile app called CesiKids, designed by nurses, recovered teens, and parents, to help adolescents aged 12-18 with cancer build psychological resilience while in the hospital. The app uses AI to adapt to each teen's needs and includes activities to strengthen coping skills. Thirty-six teens will be randomly assigned to use the app for four weeks or receive standard care, and researchers will measure changes in resilience and coping at several points. This is an early-stage trial to see if the approach is helpful and feasible.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
CesiKids mobile-based psychological resilience program (nurse-led, AI-supported mobile application)
What this could lead to
If it works, this could offer a new, scalable way to help hospitalized teens with cancer feel stronger emotionally and cope better during treatment.
What could go wrong
This is a very small early trial (36 participants) testing a new app, so results may not apply to all teens. The program is still being developed and may not show clear benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADOLESCENT CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ankara University Faculty of Medicine Cebeci Research and Practice Hospital

    Ankara, Ankara, 06620, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.